401k Plan data: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN plan

PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 401k Plan overview

Plan Name	PHARMA-BIO SERV PR, INC. RETIREMENT PLAN
Plan identification number	002

PHARMA-BIO SERV PR, INC. RETIREMENT PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
U.S.-based plan that covers residents of Puerto Rico and is qualified under both Code section 401 and section 1165 of the Puerto Rico Code.

401k Sponsoring company profile

PHARMA-BIO SERV PR, INC. has sponsored the creation of one or more 401k plans.

Company Name: PHARMA-BIO SERV PR, INC.

Employer identification number (EIN): 660549685

NAIC Classification: 541990
NAIC Description: All Other Professional, Scientific, and Technical Services

Form 5500 Filing Information

Submission information for form 5500 for 401k plan PHARMA-BIO SERV PR, INC. RETIREMENT PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
002 2022-01-01
002 2022-01-01 PEDRO LASANTA
002 2021-01-01
002 2021-01-01 PEDRO LASANTA
002 2020-01-01
002 2019-01-01
002 2017-01-01 PEDRO LASANTA
002 2016-01-01 PEDRO LASANTA
002 2015-01-01 PEDRO LASANTA
002 2014-01-01 PEDRO LASANTA
002 2013-01-01 PEDRO LASANTA

Plan Statistics for PHARMA-BIO SERV PR, INC. RETIREMENT PLAN

401k plan membership statisitcs for PHARMA-BIO SERV PR, INC. RETIREMENT PLAN

Measure Date Value
2022: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 136
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 79
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 61
Total of all active and inactive participants 2022-01-01 140
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 140
Number of participants with account balances 2022-01-01 84
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 1
2021: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 152
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 60
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 62
Total of all active and inactive participants 2021-01-01 122
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 122
Number of participants with account balances 2021-01-01 84
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 2
2020: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 137
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 87
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 57
Total of all active and inactive participants 2020-01-01 144
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 144
Number of participants with account balances 2020-01-01 87
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 3
2019: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 140
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 104
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 6
Total of all active and inactive participants 2019-01-01 110
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 110
Number of participants with account balances 2019-01-01 81
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 1
2017: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 169
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 119
Number of retired or separated participants receiving benefits 2017-01-01 1
Number of other retired or separated participants entitled to future benefits 2017-01-01 29
Total of all active and inactive participants 2017-01-01 149
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 149
Number of participants with account balances 2017-01-01 77
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 4
2016: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 160
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 142
Number of retired or separated participants receiving benefits 2016-01-01 1
Number of other retired or separated participants entitled to future benefits 2016-01-01 29
Total of all active and inactive participants 2016-01-01 172
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 172
Number of participants with account balances 2016-01-01 81
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 4
2015: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 228
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 113
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 33
Total of all active and inactive participants 2015-01-01 146
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 146
Number of participants with account balances 2015-01-01 89
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 6
2014: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 204
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 112
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 96
Total of all active and inactive participants 2014-01-01 208
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 1
Total participants 2014-01-01 209
Number of participants with account balances 2014-01-01 163
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 5
2013: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 152
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 129
Number of retired or separated participants receiving benefits 2013-01-01 10
Number of other retired or separated participants entitled to future benefits 2013-01-01 71
Total of all active and inactive participants 2013-01-01 210
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 210
Number of participants with account balances 2013-01-01 157
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 2

Measure	Date	Value
2022: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	136
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	79
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	61
Total of all active and inactive participants	2022-01-01	140
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	140
Number of participants with account balances	2022-01-01	84
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	1
2021: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	152
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	60
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	62
Total of all active and inactive participants	2021-01-01	122
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	122
Number of participants with account balances	2021-01-01	84
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	2
2020: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	137
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	87
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	57
Total of all active and inactive participants	2020-01-01	144
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	144
Number of participants with account balances	2020-01-01	87
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	3
2019: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	140
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	104
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	6
Total of all active and inactive participants	2019-01-01	110
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	110
Number of participants with account balances	2019-01-01	81
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	1
2017: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	169
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	119
Number of retired or separated participants receiving benefits	2017-01-01	1
Number of other retired or separated participants entitled to future benefits	2017-01-01	29
Total of all active and inactive participants	2017-01-01	149
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	149
Number of participants with account balances	2017-01-01	77
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	4
2016: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	160
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	142
Number of retired or separated participants receiving benefits	2016-01-01	1
Number of other retired or separated participants entitled to future benefits	2016-01-01	29
Total of all active and inactive participants	2016-01-01	172
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	172
Number of participants with account balances	2016-01-01	81
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	4
2015: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	228
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	113
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	33
Total of all active and inactive participants	2015-01-01	146
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	146
Number of participants with account balances	2015-01-01	89
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	6
2014: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	204
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	112
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	96
Total of all active and inactive participants	2014-01-01	208
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	1
Total participants	2014-01-01	209
Number of participants with account balances	2014-01-01	163
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	5
2013: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	152
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	129
Number of retired or separated participants receiving benefits	2013-01-01	10
Number of other retired or separated participants entitled to future benefits	2013-01-01	71
Total of all active and inactive participants	2013-01-01	210
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	210
Number of participants with account balances	2013-01-01	157
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	2

Financial Data on PHARMA-BIO SERV PR, INC. RETIREMENT PLAN

Measure	Date	Value
2022 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-609,872
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$161,442
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$92,946
Expenses. Certain deemed distributions of participant loans	2022-12-31	$1,929
Value of total corrective distributions	2022-12-31	$37,361
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$308,802
Value of total assets at end of year	2022-12-31	$3,478,241
Value of total assets at beginning of year	2022-12-31	$4,249,555
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$29,206
Total interest from all sources	2022-12-31	$4,180
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$36,148
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$183,457
Participant contributions at end of year	2022-12-31	$35,900
Participant contributions at beginning of year	2022-12-31	$54,754
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-12-31	$0
Administrative expenses (other) incurred	2022-12-31	$29,206
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-771,314
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$3,478,241
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$4,249,555
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$1,767,799
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$3,181,543
Interest on participant loans	2022-12-31	$2,035
Interest earned on other investments	2022-12-31	$2,145
Value of interest in common/collective trusts at end of year	2022-12-31	$1,445,867
Value of interest in common/collective trusts at beginning of year	2022-12-31	$784,638
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$228,675
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$228,620
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-885,238
Net investment gain or loss from common/collective trusts	2022-12-31	$-73,764
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	Yes
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$125,345
Employer contributions (assets) at end of year	2022-12-31	$0
Employer contributions (assets) at beginning of year	2022-12-31	$0
Income. Dividends from common stock	2022-12-31	$36,148
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$92,946
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	CROWE PR, PSC
Accountancy firm EIN	2022-12-31	660539048
Total unrealized appreciation/depreciation of assets	2022-01-01	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-01-01	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-01-01	$0
Total income from all sources (including contributions)	2022-01-01	$-609,872
Total loss/gain on sale of assets	2022-01-01	$0
Total of all expenses incurred	2022-01-01	$161,442
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-01-01	$92,946
Expenses. Certain deemed distributions of participant loans	2022-01-01	$1,929
Value of total corrective distributions	2022-01-01	$37,361
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-01-01	$308,802
Value of total assets at end of year	2022-01-01	$3,478,241
Value of total assets at beginning of year	2022-01-01	$4,249,555
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-01-01	$29,206
Total interest from all sources	2022-01-01	$4,180
Total dividends received (eg from common stock, registered investment company shares)	2022-01-01	$36,148
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-01-01	No
Was this plan covered by a fidelity bond	2022-01-01	Yes
Value of fidelity bond cover	2022-01-01	$1,000,000
If this is an individual account plan, was there a blackout period	2022-01-01	No
Were there any nonexempt tranactions with any party-in-interest	2022-01-01	No
Contributions received from participants	2022-01-01	$183,457
Participant contributions at end of year	2022-01-01	$35,900
Participant contributions at beginning of year	2022-01-01	$54,754
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-01-01	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-01-01	$0
Administrative expenses (other) incurred	2022-01-01	$29,206
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-01-01	No
Value of net income/loss	2022-01-01	$-771,314
Value of net assets at end of year (total assets less liabilities)	2022-01-01	$3,478,241
Value of net assets at beginning of year (total assets less liabilities)	2022-01-01	$4,249,555
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-01-01	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-01-01	No
Were any leases to which the plan was party in default or uncollectible	2022-01-01	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-01-01	$1,767,799
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-01-01	$3,181,543
Interest on participant loans	2022-01-01	$2,035
Interest earned on other investments	2022-01-01	$2,145
Value of interest in common/collective trusts at end of year	2022-01-01	$1,445,867
Value of interest in common/collective trusts at beginning of year	2022-01-01	$784,638
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-01-01	$228,675
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-01-01	$228,620
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-01-01	$-885,238
Net investment gain or loss from common/collective trusts	2022-01-01	$-73,764
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-01-01	Yes
Was there a failure to transmit to the plan any participant contributions	2022-01-01	No
Has the plan failed to provide any benefit when due under the plan	2022-01-01	No
Contributions received in cash from employer	2022-01-01	$125,345
Employer contributions (assets) at end of year	2022-01-01	$0
Employer contributions (assets) at beginning of year	2022-01-01	$0
Income. Dividends from common stock	2022-01-01	$36,148
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-01-01	$92,946
Did the plan have assets held for investment	2022-01-01	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-01-01	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-01-01	No
Opinion of an independent qualified public accountant for this plan	2022-01-01	1
Accountancy firm name	2022-01-01	CROWE PR, PSC
Accountancy firm EIN	2022-01-01	660539048
2021 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$711,617
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$318,824
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$277,986
Value of total corrective distributions	2021-12-31	$10,892
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$320,300
Value of total assets at end of year	2021-12-31	$4,249,555
Value of total assets at beginning of year	2021-12-31	$3,856,762
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$29,946
Total interest from all sources	2021-12-31	$3,870
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$233,144
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$233,144
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$192,332
Participant contributions at end of year	2021-12-31	$54,754
Participant contributions at beginning of year	2021-12-31	$14,848
Participant contributions at end of year	2021-12-31	$0
Participant contributions at beginning of year	2021-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$392,793
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$4,249,555
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$3,856,762
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$29,946
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$3,181,543
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$3,031,458
Interest on participant loans	2021-12-31	$1,880
Interest earned on other investments	2021-12-31	$1,990
Value of interest in common/collective trusts at end of year	2021-12-31	$784,638
Value of interest in common/collective trusts at beginning of year	2021-12-31	$590,409
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$228,620
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$220,047
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$154,303
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$127,968
Employer contributions (assets) at end of year	2021-12-31	$0
Employer contributions (assets) at beginning of year	2021-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$277,986
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	CROWE PR, PSC
Accountancy firm EIN	2021-12-31	660539048
2020 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$1,092,307
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$177,823
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$138,261
Value of total corrective distributions	2020-12-31	$15,332
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$351,722
Value of total assets at end of year	2020-12-31	$3,856,762
Value of total assets at beginning of year	2020-12-31	$2,942,278
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$24,230
Total interest from all sources	2020-12-31	$1,003
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$150,805
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$150,805
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$213,913
Participant contributions at end of year	2020-12-31	$14,848
Participant contributions at beginning of year	2020-12-31	$21,317
Participant contributions at end of year	2020-12-31	$0
Participant contributions at beginning of year	2020-12-31	$0
Other income not declared elsewhere	2020-12-31	$588,777
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$914,484
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$3,856,762
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$2,942,278
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$3,031,458
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$2,663,332
Interest on participant loans	2020-12-31	$1,003
Value of interest in common/collective trusts at end of year	2020-12-31	$590,409
Value of interest in common/collective trusts at beginning of year	2020-12-31	$33,746
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$220,047
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$223,883
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$137,809
Employer contributions (assets) at end of year	2020-12-31	$0
Employer contributions (assets) at beginning of year	2020-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$138,261
Contract administrator fees	2020-12-31	$24,230
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	CROWE PR, PSC
Accountancy firm EIN	2020-12-31	660539048
2019 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$752,792
Total income from all sources (including contributions)	2019-12-31	$752,792
Total loss/gain on sale of assets	2019-12-31	$0
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$42,440
Total of all expenses incurred	2019-12-31	$42,440
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$9,709
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$9,709
Value of total corrective distributions	2019-12-31	$14,974
Value of total corrective distributions	2019-12-31	$14,974
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$285,642
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$285,642
Value of total assets at end of year	2019-12-31	$2,942,278
Value of total assets at end of year	2019-12-31	$2,942,278
Value of total assets at beginning of year	2019-12-31	$2,231,926
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$17,757
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$17,757
Total interest from all sources	2019-12-31	$1,348
Total interest from all sources	2019-12-31	$1,348
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$111,916
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$111,916
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$111,916
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$111,916
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$3,000,000
Value of fidelity bond cover	2019-12-31	$3,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	Yes
If this is an individual account plan, was there a blackout period	2019-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$198,744
Contributions received from participants	2019-12-31	$198,744
Participant contributions at end of year	2019-12-31	$21,317
Participant contributions at end of year	2019-12-31	$21,317
Participant contributions at beginning of year	2019-12-31	$27,440
Participant contributions at beginning of year	2019-12-31	$27,440
Participant contributions at end of year	2019-12-31	$0
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$710,352
Value of net income/loss	2019-12-31	$710,352
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$2,942,278
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$2,942,278
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$2,231,926
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$2,231,926
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$2,663,332
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$2,663,332
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$0
Value of interest in pooled separate accounts at end of year	2019-12-31	$33,746
Value of interest in pooled separate accounts at end of year	2019-12-31	$33,746
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$1,937,626
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$1,937,626
Interest on participant loans	2019-12-31	$1,348
Interest on participant loans	2019-12-31	$1,348
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$223,883
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$223,883
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$266,860
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$266,860
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$353,886
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$353,886
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$86,898
Contributions received in cash from employer	2019-12-31	$86,898
Employer contributions (assets) at end of year	2019-12-31	$0
Employer contributions (assets) at end of year	2019-12-31	$0
Employer contributions (assets) at beginning of year	2019-12-31	$0
Employer contributions (assets) at beginning of year	2019-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$9,709
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$9,709
Contract administrator fees	2019-12-31	$17,757
Contract administrator fees	2019-12-31	$17,757
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	Yes
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	CROWE PR, PSC
Accountancy firm name	2019-12-31	CROWE PR, PSC
Accountancy firm EIN	2019-12-31	660539048
Accountancy firm EIN	2019-12-31	660539048
2018 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$27,198
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$81,156
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$23,487
Value of total corrective distributions	2018-12-31	$34,757
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$182,143
Value of total assets at end of year	2018-12-31	$2,231,926
Value of total assets at beginning of year	2018-12-31	$2,285,884
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$22,912
Total interest from all sources	2018-12-31	$1,550
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$182,143
Participant contributions at end of year	2018-12-31	$27,440
Participant contributions at beginning of year	2018-12-31	$0
Participant contributions at end of year	2018-12-31	$0
Participant contributions at beginning of year	2018-12-31	$5,929
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-53,958
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$2,231,926
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$2,285,884
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in pooled separate accounts at end of year	2018-12-31	$1,937,626
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$1,997,973
Interest on participant loans	2018-12-31	$1,550
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$266,860
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$281,982
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-156,495
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Employer contributions (assets) at end of year	2018-12-31	$0
Employer contributions (assets) at beginning of year	2018-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$23,487
Contract administrator fees	2018-12-31	$22,912
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	No
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	CROWE PR, PSC
Accountancy firm EIN	2018-12-31	660539048
2017 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$523,577
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$145,647
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$100,916
Value of total corrective distributions	2017-12-31	$23,880
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$246,534
Value of total assets at end of year	2017-12-31	$2,285,884
Value of total assets at beginning of year	2017-12-31	$1,907,954
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$20,851
Total interest from all sources	2017-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$192,327
Participant contributions at end of year	2017-12-31	$5,929
Participant contributions at beginning of year	2017-12-31	$6,044
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$377,930
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$2,285,884
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$1,907,954
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in pooled separate accounts at end of year	2017-12-31	$1,997,973
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$1,627,668
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2017-12-31	$281,982
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2017-12-31	$271,111
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$277,043
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$54,207
Employer contributions (assets) at end of year	2017-12-31	$0
Employer contributions (assets) at beginning of year	2017-12-31	$3,131
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$100,916
Contract administrator fees	2017-12-31	$20,851
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2017-12-31	No
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	CROWE PR, PSC
Accountancy firm EIN	2017-12-31	660539048
2016 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$387,716
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$156,121
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$133,791
Value of total corrective distributions	2016-12-31	$3,534
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$258,727
Value of total assets at end of year	2016-12-31	$1,907,954
Value of total assets at beginning of year	2016-12-31	$1,676,359
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$18,796
Total interest from all sources	2016-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	Yes
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$172,606
Participant contributions at end of year	2016-12-31	$6,044
Participant contributions at beginning of year	2016-12-31	$11,094
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2016-12-31	$850
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$231,595
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$1,907,954
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$1,676,359
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in pooled separate accounts at end of year	2016-12-31	$1,627,668
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$1,324,519
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2016-12-31	$271,111
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2016-12-31	$335,843
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$128,989
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$86,121
Employer contributions (assets) at end of year	2016-12-31	$3,131
Employer contributions (assets) at beginning of year	2016-12-31	$4,903
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$132,941
Contract administrator fees	2016-12-31	$18,796
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2016-12-31	Yes
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	HORWATH VELEZ & CO., PSC
Accountancy firm EIN	2016-12-31	660539048
2015 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$249,564
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$245,303
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$245,303
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$244,313
Value of total assets at end of year	2015-12-31	$1,676,359
Value of total assets at beginning of year	2015-12-31	$1,672,098
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$0
Total interest from all sources	2015-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$161,187
Participant contributions at end of year	2015-12-31	$11,094
Participant contributions at beginning of year	2015-12-31	$5,443
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$25,000
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2015-12-31	$15,875
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$4,261
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$1,676,359
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$1,672,098
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in pooled separate accounts at end of year	2015-12-31	$1,324,519
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$1,365,557
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2015-12-31	$335,843
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2015-12-31	$298,591
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$5,251
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$58,126
Employer contributions (assets) at end of year	2015-12-31	$4,903
Employer contributions (assets) at beginning of year	2015-12-31	$2,507
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$229,428
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2015-12-31	Yes
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	HORWATH VELEZ & CO., PSC
Accountancy firm EIN	2015-12-31	660539048
2014 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$334,734
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$151,652
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$151,652
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$237,595
Value of total assets at end of year	2014-12-31	$1,672,098
Value of total assets at beginning of year	2014-12-31	$1,489,016
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$0
Total interest from all sources	2014-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2014-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$152,763
Participant contributions at end of year	2014-12-31	$5,443
Participant contributions at beginning of year	2014-12-31	$10,984
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2014-12-31	$10,839
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2014-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2014-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$183,082
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$1,672,098
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$1,489,016
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in pooled separate accounts at end of year	2014-12-31	$1,365,557
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$1,222,376
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2014-12-31	$298,591
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2014-12-31	$249,341
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$97,139
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$84,832
Employer contributions (assets) at end of year	2014-12-31	$2,507
Employer contributions (assets) at beginning of year	2014-12-31	$6,315
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$140,813
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2014-12-31	Yes
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	HORWATH VELEZ & CO., PSC
Accountancy firm EIN	2014-12-31	660539048
2013 : PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total transfer of assets to this plan	2013-12-31	$1,189,774
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$430,106
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$130,864
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$121,422
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$184,380
Value of total assets at end of year	2013-12-31	$1,489,016
Value of total assets at beginning of year	2013-12-31	$0
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$9,442
Total interest from all sources	2013-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2013-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$100,523
Participant contributions at end of year	2013-12-31	$10,984
Participant contributions at beginning of year	2013-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$299,242
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$1,489,016
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$0
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in pooled separate accounts at end of year	2013-12-31	$1,222,376
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2013-12-31	$249,341
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2013-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$10,802
Net investment gain/loss from pooled separate accounts	2013-12-31	$234,924
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$83,857
Employer contributions (assets) at end of year	2013-12-31	$6,315
Employer contributions (assets) at beginning of year	2013-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$121,422
Contract administrator fees	2013-12-31	$9,442
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2013-12-31	Yes
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	HORWATH VELEZ & CO., PSC
Accountancy firm EIN	2013-12-31	660539048

Form 5500 Responses for PHARMA-BIO SERV PR, INC. RETIREMENT PLAN

2022: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2017: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Insurance	Yes
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement – Insurance	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Insurance	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement – Insurance	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Insurance	Yes
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement – Insurance	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Insurance	Yes
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement – Insurance	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: PHARMA-BIO SERV PR, INC. RETIREMENT PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	First time form 5500 has been submitted	Yes
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Insurance	Yes
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement – Insurance	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

506680-P1

Policy instance

Insurance contract or identification number	506680-P1
Number of Individuals Covered	140
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

506680-P1

Policy instance

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

506680-P1

Policy instance

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

987257-000

Policy instance

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

506680-P1

Policy instance

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

987257-000

Policy instance

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

987257-000

Policy instance

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

987257-000

Policy instance

TRANSAMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 86231 )

Policy contract number

987257-000

Policy instance

Potentially related plans

PHARMA-BIO SERV US, INC RETIREMENT PLAN [EIN = 263095130]

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	PHARMA-BIO SERV PR, INC.
Employer identification number (EIN):	660549685
NAIC Classification:	541990
NAIC Description:	All Other Professional, Scientific, and Technical Services

Plan id#	Filing Submission Date	Name of Administrator
002	2022-01-01
002	2022-01-01	PEDRO LASANTA
002	2021-01-01
002	2021-01-01	PEDRO LASANTA
002	2020-01-01
002	2019-01-01
002	2017-01-01	PEDRO LASANTA
002	2016-01-01	PEDRO LASANTA
002	2015-01-01	PEDRO LASANTA
002	2014-01-01	PEDRO LASANTA
002	2013-01-01	PEDRO LASANTA